B. Riley Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$70.6K Buy
+681
New +$139K 0.08% 65
2015
Q3
Sell
-410
Closed -$165K 204
2015
Q2
$165K Buy
410
+300
+273% +$120K 0.13% 208
2015
Q1
$46K Buy
110
+10
+10% +$3.94K 0.03% 421
2014
Q4
$33K Hold
100
0.03% 470
2014
Q3
$33K Sell
100
-679
-87% -$224K 0.02% 498
2014
Q2
$245K Sell
779
-7
-0.9% -$2.11K 0.16% 174
2014
Q1
$240K Buy
+786
New +$250K 0.18% 155

Other funds holding BIIB

B. Riley Wealth Management's BIIB Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Biogen (BIIB) in Q2 2022: 681 shares worth $70.6K. The stake represents 0.08% of the portfolio and ranks #65 among its holdings. This is a return to the name: B. Riley Wealth Management previously reported a position in BIIB as recently as Q2 2015.

B. Riley Wealth Management first reported a position in BIIB in Q1 2014 and has held it in 7 quarters since. The position peaked at $245K in Q2 2014. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • B. Riley Wealth Management held 681 shares of Biogen worth $70.6K as of Q2 2022.
  • Biogen was a new B. Riley Wealth Management position in Q2 2022.
  • Biogen made up 0.08% of B. Riley Wealth Management's portfolio in Q2 2022, its #65 holding.
  • B. Riley Wealth Management first reported a position in Biogen in Q1 2014 and has held it in 7 quarters since.
  • B. Riley Wealth Management's Biogen position peaked at $245K in Q2 2014.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.